The first Cardiac Motion external wearable monitor "CardiaScan™" uses low power contact radar to measure changes in heart wall motion in heart failure patients. The measured changes in heart wall motion closely correlate to changes in pulmonary artery pressure (PAP), a key indicator of heart decompensation, and the gold standard for proactively adjusting medications to maintain patient health and prevent rehospitalization.
Today, one of the best PAP monitors available to some heart failure patients is the surgically implanted Abbott CardioMEMS sensor. As a non-invasive, external, ambulatory health monitoring device, the vision for CardiaScan is to easily enable all heart failure patients to non-invasively monitor and address heart decompensation indications while at home, and to complement monitoring of those patients who have or are candidates for implanted CardioMEMS devices.
Today, one of the best PAP monitors available to some heart failure patients is the surgically implanted Abbott CardioMEMS sensor. As a non-invasive, external, ambulatory health monitoring device, the vision for CardiaScan is to easily enable all heart failure patients to non-invasively monitor and address heart decompensation indications while at home, and to complement monitoring of those patients who have or are candidates for implanted CardioMEMS devices.
|
|
|